Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 15;154(10):1683-1693.
doi: 10.1002/ijc.34849. Epub 2024 Jan 17.

Recent advances in breast cancer cell line research

Affiliations
Review

Recent advances in breast cancer cell line research

Manika P Sharma et al. Int J Cancer. .

Abstract

Breast cancer, a formidable global health challenge, needs continuous translational research to understand the complexity of mechanisms and improve therapeutic and diagnostic strategies. Breast cancer cell lines are of paramount importance as they significantly contribute to the initial stage of research to understand cancer biology. This review provides insights into targeted therapies and immunotherapies that have emerged using in vitro models and microbiome analysis. It focuses on therapeutic development using cell lines and the limitations of tumor heterogeneity and microenvironment. We explore the evolving landscape of breast cancer cell lines from two-dimensional (2-D) cultures to patient-derived xenograft (PDX) models advancing both fundamental and translational research. Patient-derived xenografts, cell line-derived xenografts (CDX), three-dimensional (3-D) cultures, organoids, and circulating tumor cells (CTC) models provide promising alternatives that capture the intricacies of the tumor microenvironment. This review bridges the gap between traditional cell lines and newer developments exploring the therapeutic and diagnostic advancements and needs for cell lines to expedite the progress in breast cancer research and treatment.

Keywords: breast cancer; cell cultures; cell line development; therapeutics; xenografts.

PubMed Disclaimer

References

REFERENCES

    1. WHO. Breast Cancer Details. 2023. Accessed July 2023. https://www.who.int/news-room/fact-sheets/detail/breast-cancer
    1. Globocan. TGCO. Estimated Age-Standardized Incidence Rates (World) in 2020, India, Both Sexes, All Ages (excl. NMSC). 2020. Accessed July 2023. https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-she...
    1. Fatima I, Singh AB, Dhawan P. MASTL: a novel therapeutic target for cancer malignancy. Cancer Med. 2020;9(17):6322-6329.
    1. Polisety A, Misra G, Rajawat J, Katiyar A, Singh H, Bhatt AN. Therapeutic natural compounds Enzastaurin and Palbociclib inhibit MASTL kinase activity preventing breast cancer cell proliferation. Med Oncol. 2022;39(5):100.
    1. Misra G, Rajawat J, Pal R, Smith JC, Kumar A. Targeted inhibition of MASTL kinase activity induces apoptosis in breast cancer. Life Sci. 2023;334:122250.

LinkOut - more resources